Esto es lo que debes saber antes de tu primera cita
Olpasiran (AMG890) has shown a dose-dependent significant reduction in Lp(a) concentrations [235], OCEAN(a)-Outcome (NCT05581303) is an ongoing phase III clinical trial designed to study its long-term effects on MACE
Perform hand hygiene and don appropriate PPE (gloves, gown, mask) in accordance with institutional SOP
If you're from an Asian, Chinese, Middle Eastern, Black African or African-Caribbean background you may qualify for Wegovy with a lower BMI
By promoting the clearance of these dysfunctional cells, FOXO4-DRI holds promise as a therapeutic agent in rejuvenating tissues and improving healthspan
The results of the Shapiro-Wilk Test indicated that the data are normally distributed, with a p-value greater than 0.05